You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
Discover the Doptelet Copay
Assistance Program
Terms and Conditions
There’s only one pill that can raise your platelets to 50,000 per microliter in as little as 8 days—without placing any limits on when you can eat certain foods. It's called Doptelet.
With Doptelet, you don’t need to worry about when you eat certain foods because of treatment. You can have dairy before bed without setting the alarm. Or you can enjoy a bowl of cereal at breakfast without waking up at 5 AM. It’s totally up to you!
Plus, Doptelet isn’t an injection–it’s a pill with no significant risk for liver damage or developing cataracts. That means fewer visits to your doctor’s office for liver testing, eye exams, or treatment injections.
playing: false
Tammy has been living with chronic ITP for 15 years and was looking for a treatment that would lift platelets fast and keep them stable. When it came to starting on Doptelet, she only had one regret—that she didn’t start sooner. Watch Tammy’s story.
Dealing with insurance companies and figuring out how to pay for your treatment can be stressful. Don’t worry. Doptelet Connect can partner with you and your doctor to help you with:
*In order to participate in the Doptelet Free Trial Offer, a patient must be new to Doptelet therapy and be aged ≥18 years. The patient must be prescribed Doptelet for an approved on-label indication (ITP only) and be under the care of a licensed healthcare provider who is authorized to prescribe medicine in the United States or US Territories and the patient must reside in the United States or US Territories. Additionally, a patient can only participate in the Doptelet Free Trial Offer once. The offer is void where prohibited by law. Certain rules and restrictions apply. Sobi reserves the right to revoke, rescind, or amend this offer without notice.
Get the ball rolling on a new chapter in your treatment journey. Prepare for your next appointment with our discussion guide and talk to your doctor about starting on Doptelet.
INDICATION & IMPORTANT SAFETY INFORMATION
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
What is DOPTELET® (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
This website uses cookies. By continuing to
use this website, you consent to our use of these cookies. Read more about our use of cookies